| Microorganism |
MIC50
(μg/ml) |
MIC90
(μg/ml) |
Range
(μg/ml) |
Antimicrobial |
Reference |
| Staphylococcus aureus (710A) |
- |
- |
2 － ? |
P2 (Gly7)  |
632 |
| Staphylococcus aureus (710A) |
- |
- |
2 － ? |
P9 (Gly7) |
632 |
| Staphylococcus aureus (710A) |
- |
- |
4 － ? |
mfaBD2 |
626 |
| Staphylococcus aureus (710A) |
- |
- |
4 － ? |
P8 (Ala7) |
632 |
| Staphylococcus aureus (710A) |
- |
- |
4 － ? |
tBD |
626 |
| Staphylococcus aureus (710A) |
- |
- |
8 － 16 |
HBD2 |
626 |
| Staphylococcus aureus (710A) |
- |
- |
≥32 － ? |
P10 (Gly7,14) |
632 |
| Staphylococcus aureus (710A) |
- |
- |
>32 － ? |
P11 (Gly14) |
632 |
| Staphylococcus aureus (710A) |
- |
- |
32 － ? |
P3 (Pro7) |
632 |
| Staphylococcus aureus (77) |
- |
- |
0.5 － ? |
Linezolid (PNU-100766, U-100766, Zyvox) |
224 |
| Staphylococcus aureus (77) |
- |
- |
1 － ? |
Vancomycin (Vancocyn, Lyphocin) |
224 |
| Staphylococcus aureus (8 + methicillin-susceptible) |
- |
- |
0.06 － ? |
Moxifloxacin (BAY 12-8039, Avelox) |
207 |
| Staphylococcus aureus (8 + methicillin-susceptible) |
- |
- |
0.125 － ? |
Gatifloxacin (Tequin) |
207 |
| Staphylococcus aureus (8 + methicillin-susceptible) |
- |
- |
0.25 － ? |
Dalbavancin |
72 |
| Staphylococcus aureus (8 + methicillin-susceptible) |
- |
- |
0.25 － ? |
Levofloxacin (Levaquin, Quixin) |
207 |
| Staphylococcus aureus (8 + methicillin-susceptible) |
- |
- |
0.25 － ? |
Oritavancin (LY333328) |
72 |
| Staphylococcus aureus (8 + methicillin-susceptible) |
- |
- |
0.25 － ? |
Oritavancin (LY333328) |
207 |
| Staphylococcus aureus (8 + methicillin-susceptible) |
- |
- |
0.25 － ? |
Quinupristin/Dalfopristin (Synercid) |
207 |
| Staphylococcus aureus (8 + methicillin-susceptible) |
- |
- |
0.25 － ? |
Quinupristin/Dalfopristin (Synercid) |
72 |
| Staphylococcus aureus (8 + methicillin-susceptible) |
- |
- |
0.5 － ? |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
207 |
| Staphylococcus aureus (8 + methicillin-susceptible) |
- |
- |
0.5 － ? |
Daptomycin (Cubicin) |
72 |
| Staphylococcus aureus (8 + methicillin-susceptible) |
- |
- |
0.5 － ? |
Daptomycin (Cubicin) |
207 |
| Staphylococcus aureus (8 + methicillin-susceptible) |
- |
- |
0.5 － ? |
Teicoplanin (Targocid) |
207 |
| Staphylococcus aureus (8 + methicillin-susceptible) |
- |
- |
0.5 － ? |
Teicoplanin (Targocid) |
72 |
| Staphylococcus aureus (8 + methicillin-susceptible) |
- |
- |
1 － ? |
LBM415 (NVP-PDF-713, VIC-10495) |
207 |
| Staphylococcus aureus (8 + methicillin-susceptible) |
- |
- |
1 － ? |
Vancomycin (Vancocyn, Lyphocin) |
207 |
| Staphylococcus aureus (8 + methicillin-susceptible) |
- |
- |
1 － ? |
Vancomycin (Vancocyn, Lyphocin) |
72 |
| Staphylococcus aureus (8 + methicillin-susceptible) |
- |
- |
2 － ? |
Linezolid (PNU-100766, U-100766, Zyvox) |
207 |